Source link : https://www.newshealth.biz/health-news/metformin-fails-to-stop-early-prostate-cancer-progression/
CHICAGO — Use of metformin didn’t prevent progression of low-risk localized prostate cancer in patients on active surveillance, according to data from the randomized MAST study. There was no statistically significant difference in progression-free survival (PFS) between patients treated with metformin and those receiving placebo when analyzing PFS using various definitions: Pathologic progression: HR 1.07 […]
Author : News Health
Publish date : 2024-06-05 14:59:16
Copyright for syndicated content belongs to the linked Source.
Categories